Publicacións nas que colabora con Jesús Joglar Tamargo (20)

2015

  1. Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats

    DMM Disease Models and Mechanisms, Vol. 8, Núm. 10, pp. 1213-1225

2013

  1. Dose-dependent metabolic disposition of hydroxytyrosol and formation of mercapturates in rats

    Pharmacological Research, Vol. 77, pp. 47-56

2012

  1. Unsaturated fatty alcohol derivatives of olive oil phenolic compounds with potential low-density lipoprotein (LDL) antioxidant and antiobesity properties

    Journal of Agricultural and Food Chemistry, Vol. 60, Núm. 4, pp. 1067-1074

2011

  1. Direct analysis of glucuronidated metabolites of main olive oil phenols in human urine after dietary consumption of virgin olive oil

    Food Chemistry, Vol. 126, Núm. 1, pp. 306-314

2010

  1. Antioxidant activities of hydroxytyrosol main metabolites do not contribute to beneficial health effects after olive oil ingestion

    Drug Metabolism and Disposition, Vol. 38, Núm. 9, pp. 1417-1421

  2. Matrix effects on the bioavailability of resveratrol in humans

    Food Chemistry, Vol. 120, Núm. 4, pp. 1123-1130

  3. Synthesis of fatty acid amides of catechol metabolites that exhibit antiobesity properties

    ChemMedChem, Vol. 5, Núm. 10, pp. 1781-1787

2009

  1. Enzymatic Synthesis of Glycosides and Glucuronides

    Practical Methods for Biocatalysis and Biotransformations (John Wiley & Sons, Ltd), pp. 227-231

  2. Neurotoxic thioether adducts of 3,4-methylenedioxymethamphetamine identified in human urine after ecstasy ingestion

    Drug Metabolism and Disposition, Vol. 37, Núm. 7, pp. 1448-1455

2008

  1. Serotonergic neurotoxic thioether metabolites of 3,4- methylenedioxymethamphetamine (MDMA, "ecstasy"): Synthesis, isolation, and characterization of diastereoisomers

    Chemical Research in Toxicology, Vol. 21, Núm. 12, pp. 2272-2279

2006

  1. Biocatalyzed synthesis and structural characterization of monoglucuronides of hydroxytyrosol, tyrosol, homovanillic alcohol, and 3-(4′-hydroxyphenyl) propanol

    Advanced Synthesis and Catalysis, Vol. 348, Núm. 15, pp. 2155-2162

  2. Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans

    Free Radical Biology and Medicine, Vol. 40, Núm. 4, pp. 608-616

2004

  1. Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine)

    Drug Metabolism and Disposition, Vol. 32, Núm. 9, pp. 1001-1007

2003

  1. Quantitative determination of paroxetine and its 4-hydroxy-3-methoxy metabolite in plasma by high-performance liquid chromatography/electrospray ion trap mass spectrometry: Application to pharmacokinetic studies

    Rapid Communications in Mass Spectrometry, Vol. 17, Núm. 13, pp. 1455-1461

  2. Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites by gas chromatography/mass spectrometry

    Rapid Communications in Mass Spectrometry, Vol. 17, Núm. 4, pp. 330-336

  3. Synthesis of the major metabolites of Paroxetine

    Bioorganic Chemistry, Vol. 31, Núm. 3, pp. 248-258

2002

  1. Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis

    Journal of Analytical Toxicology, Vol. 26, Núm. 3, pp. 157-165

  2. High-performance liquid chromatography with electrochemical detection applied to the analysis of 3,4-dihydroxymethamphetamine in human plasma and urine

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 769, Núm. 2, pp. 313-321

  3. Synthesis and capillary electrophoretic analysis of enantiomerically enriched reference standards of MDMA and its main metabolites

    Bioorganic and Medicinal Chemistry, Vol. 10, Núm. 4, pp. 1085-1092

2001

  1. 3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans

    Chemical Research in Toxicology, Vol. 14, Núm. 9, pp. 1203-1208